| Particulars |
|
|
|
| Company Name
| Goldline Pharmaceutical Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
9.60 |
B.V. (₹) |
21.00 |
| Sales(₹ Cr.) |
28.06 |
NP (₹ Cr.) |
2.90 |
| NP Var (%) |
58.00 |
Div% |
0.00 |
| CPS(₹) |
3.30 |
EPS (₹) |
3.00 |
| Traded Value(₹ Lakhs) |
158.46 |
52 Week High |
60.00 |
| 52 Week Low |
42.00 |
Price BSE |
46.00 |
| P/C Ratio |
14.00 |
P/E Ratio |
15.20 |
| Price Vs.BV |
2.19 |
|
| Latest Quarter |
| Year End |
0 |
Sales (₹ Cr.) |
0.00 |
| NP(₹ Cr.) |
0.00 |
NP Var % |
0.00 |
| Trailing Twelve Months |
| Year End |
0 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
0.00 |
| NP Var (%) |
|
EPS |
0.00 |
| PE |
0.00 |
|
|